Centre Hospitalier Universitaire De Besancon

This study tests whether adding a cancer vaccine (UCPVax) to standard treatment (atezolizumab plus bevacizumab) can shrink tumors better than standard treatment alone in people with advanced liver cancer that cannot be removed by surgery. About 105 adults who have not had prior s…

This study tests a new drug called MP0317, which activates the immune system specifically within tumors, combined with standard chemotherapy and immunotherapy. The goal is to see if this combination can stop advanced bile duct cancer from growing for at least 12 months. About 75 …

This study is testing a new blood test to quickly identify people who may have colorectal cancer. The goal is to help doctors decide who needs urgent care, especially when colonoscopy appointments are delayed. About 400 adults with suspected or confirmed colorectal cancer will ta…

This study aims to find substances in the blood that can tell the difference between cancerous and non-cancerous pancreatic lesions. Currently, no simple blood test exists for pancreatic cancer diagnosis. Researchers will compare blood samples from 100 people with benign pancreat…

This study looks at whether a supervised exercise program can improve sleep quality in people with alcohol use disorder. Researchers will recruit 40 adults who have trouble sleeping and drink heavily. Participants will take part in physical activity sessions and track their sleep…

This study aims to find biological markers that can predict how well liver cancer patients respond to a combination of two immunotherapy drugs (tremelimumab and durvalumab). Researchers will follow 120 adults with advanced liver cancer who have not had prior systemic treatment. T…

This study looks at whether it's possible to measure sleep in regular video game players compared to non-players. Researchers will track sleep using wrist monitors, diaries, and urine tests in 40 adults aged 18 to 40. The goal is to find out what works best for a larger future st…